Related Experiment Videos
Repressed classical complement pathway activities and clinical correlations in chronic lymphocytic leukaemia
Acta Medica Hungarica
|January 1, 1986
Summary
Low levels of complement proteins C1 and C4, along with immunoglobulins, are common in chronic lymphocytic leukemia (CLL) patients, increasing infection risk, especially early in the disease.
Area of Science:
- Immunology
- Hematology
- Clinical Chemistry
Background:
- Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by immune dysregulation.
- Patients with CLL often experience increased susceptibility to infections.
- The role of complement system deficiencies in CLL pathogenesis and infection risk requires further elucidation.
Purpose of the Study:
- To investigate the levels and haemolytic activities of complement pathways (classical and alternative) in CLL patients.
- To assess the concentrations of specific complement components (C1, C4, C3, factor B, C1 inhibitor) and immunoglobulins (IgG, IgA, IgM).
- To explore the clinical correlations of these immunological parameters with disease stage and infection incidence.
Main Methods:
- Analysis of 137 serum samples from 69 patients with CLL.
- Measurement of haemolytic activities of classical and alternative complement pathways.
- Quantification of C1, C4, C3, factor B, C1 inhibitor (C1-INH), IgG, IgA, and IgM levels.
- Correlation analysis between laboratory findings and clinical data, including infection history.
Main Results:
- Depressed C1 and C4 activities were observed in nearly 50% of CLL patients.
- Hypogammaglobulinaemia (low immunoglobulin levels) occurred with similar frequency.
- Low C1 and C4 levels were predominantly found in early stages of CLL.
- A significant association was found between low C1/C4 levels and infection incidence, particularly in early disease stages.
- Low immunoglobulin levels were also linked to infections, but often present in patients without infections.
Conclusions:
- Reduced levels of complement components C1 and C4, alongside hypogammaglobulinaemia, are prevalent in CLL.
- These deficiencies, particularly low C1 and/or C4 levels, may contribute to the heightened risk of infections in CLL patients.
- The findings suggest a dual role of immunoglobulin and complement deficiencies in immune compromise during CLL, warranting further investigation into their underlying mechanisms.